Sort
34,240 grants matching “atherosclerosis”
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
$763,935Yanhong Guo · University Of Michigan At Ann Arbor · R01 · FY2025 · HL
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
$763,935Yanhong Guo · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Expectations of Discrimination and CVD Risk in Africian-American Women
$763,934Tenã T Lewis · Emory University · R01 · FY2017 · HL
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)
$763,809Jordan Blair Strom · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Mechanisms Linking Depression to Cardiovascular Risk
$763,719Viola Vaccarino Vaccarino · Emory University · R01 · FY2010 · HL
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)
$763,572Jordan Blair Strom · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin
$763,530Karol Watson · University Of California Los Angeles · N01 · FY2021 · HL
Closing the gap between observational research and randomized trials for prevention of Alzheimer's Disease and dementia
$763,265Rebecca Elizabeth Graff · University Of California, San Francisco · R01 · FY2022 · AG
Metabolic Signatures Underlying Cardiac Function for Heart Failure in Multi-Ethnic Populations
$763,166Bing Yu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · HL
The Macrovascular and Microvascular Contributions to Alzheimer's Disease: MESA VASCAD
$763,149Timothy M. Hughes · Wake Forest University Health Sciences · R01 · FY2019 · AG
Proteomic signatures to identify pathways underlying the progression to heart failure
$763,132Amil M Shah · Ut Southwestern Medical Center · R01 · FY2023 · HL
A trial to determine the effect of psoriasis treatment on cardiometabolic disease
$763,099Joel M Gelfand · University Of Pennsylvania · R01 · FY2017 · HL
Neighborhoods and Cardiovascular Risk in a Multiethnic Cohort
$762,993Ana V Diez Roux · University Of Michigan At Ann Arbor · R01 · FY2009 · HL
The Role of Perivascular Adipose Tissue in Atherosclerotic Cardiovascular Disease (PVAT-ASCVD)
$762,969Khanh-Van Thi Tran · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · HL
The biology of the sirtuins
$762,914Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
The role of autophagy in aging and metabolism
$762,914Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Comprehensive CT Guided Coronary Artery Bypass Graft Surgery
$762,896Koen Nieman · Stanford University · R01 · FY2019 · HL
Multi-Omics and Chronic Kidney Disease: Correlation with Histology
$762,855Morgan Erika Grams · New York University School Of Medicine · R01 · FY2022 · DK
Cellular Adhesion Molecules: Genes, Phenotypes, and Coronary Atherosclerosis
$762,839Myron D Gross · University Of Minnesota · R01 · FY2010 · HL
An Interpersonal Relationships Intervention for Improving Cardiovascular Health in Youth
$762,814Edith Chen · Northwestern University · R01 · FY2019 · HL
Rare variants and NHLBI traits in deeply phenotyped cohorts
$762,806Bruce M Psaty · University Of Washington · R01 · FY2014 · HL
CONTROL OF CHOLESTEROL METABOLISM -- BILE ACID TRANSPORT
$762,801University Of Texas Sw Med Ctr/Dallas · R37 · FY2003 · HL
Dietary Fat and HDL Metabolism
$762,788Frank M Sacks · Harvard School Of Public Health · R01 · FY2010 · HL
Brain-immune crosstalk in myocardial infarction
$762,703Wolfram Christian Poller · Massachusetts General Hospital · R01 · FY2025 · HL
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis
$762,674Annabelle Rodriguez · University Of Connecticut Sch Of Med/Dnt · R01 · FY2016 · HL